DV
Dividend Vision

BNTC — Benitec Biopharma Ltd ADR

Benitec Biopharma Ltd ADR (BNTC)

Total return is 128.6% over the past 12.1 years, 256.1 points behind SPY at 384.7%. Its deepest 1-year drawdown was 39.1%.

Benitec Biopharma Ltd ADR is a single-stock holding that represents American Depositary Receipts of an Australian biotechnology company. As an individual equity rather than a diversified fund, it carries concentrated company risk and does not generate a consistent dividend yield. This holding appeals primarily to investors seeking direct exposure to a specific biotech company's growth prospects rather than those pursuing regular dividend income.

BNTC key facts

Asset type
Stock
Asset class
Equity
Inception date
06/23/2014
Last close
$12.56
Market cap
$439,048,416
Average volume
169000.0
Ex-dividend date
06/01/2018
Payment date
11/18/2019
Beta
0.252
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.93